Obese persons with excess visceral fat have increased risk of diabetes
by Bruce Sylvester – Obese persons with excess visceral fat appear to be at an increased risk of developing Type 2 diabetes,
by Bruce Sylvester – Obese persons with excess visceral fat appear to be at an increased risk of developing Type 2 diabetes,
by Bruce Sylvester – taken from The British Medical Journal (BMJ) – Contradicting previous research, researchers from a study of over 44,000 women in England report that treatment… read more.
by Bruce Sylvester – take from The Journal of the American Medical Association (JAMA) – Among patients classified at intermediate risk, heart calcium scanning, known as coronary artery… read more.
by Bruce Sylvester – taken from The New England Journal of Medicine (NEJM) – Women treated with anastrozole and fulvestrant combination therapy have achieved over 6 months median… read more.
by Bruce Sylvester – taken from The Lancet – A study by Professor Peter M Rothwell, University of Oxford, UK and colleagues supports the hypothesis and adds to… read more.
by Gary Finnegan – World Health Matters (Australia) – Click here for more information Melbourne researchers are using Australia’s fasted supercomputer to simulate the motion of the complete… read more.
by Gary Finnegan – World Health Matters (Belgium) – Providing energy-dense food supplements to malnourished children in developing countries has limited effect on the weight of malnourished children,… read more.
by Gary Finnegan – World Health Matters (Canada) – Influenza vaccination rates vary widely in Canada depending on ethnicity, according to a new study in the Canadian Medical… read more.
by Gary Finnegan – World Health Matters (Sweden) – Breast cancer screening has limited or no impact on breast cancer mortality among women aged 40-69, according to a… read more.
by Maria Dalby – Biopsies taken one year after renal transplantation could be used for identifying patients at high risk of graft failure.
by Maria Dalby – Efforts continue to develop new anti-rejection agents that are as effective as the calcineurin inhibitors (CNI) but without the debilitating side effects.
by Maria Dalby – Almost all lung transplant recipients will develop bronchiolotis obliterans (BO) if they live long enough – as transplantation care is improving, BO is becoming… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.